Cumberland Pharmaceuticals Inc
CPIX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001087294
No open-market purchases or sales by Cumberland Pharmaceuticals Inc insiders were filed in the last 90 days; 32 institutions reported holding it in 13F filings for Q2 2026, worth $16.0M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Cumberland Pharmaceuticals Inc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Cumberland Pharmaceuticals Inc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Kazimi A J | Chairman and CEO | 5,695,310 | Mar 20, 2026 | 6 |
| Brown Martin S JR | Director | 10,300 | Mar 20, 2026 | 1 |
| Jones James | Director | 46,863 | Mar 20, 2026 | 5 |
| Herman James L | VP and Chief Compliance Office | 38,255 | Mar 20, 2026 | 1 |
| Galante Joseph C | Director | 63,656 | Mar 20, 2026 | 1 |
| Young Caroline | Director | 35,109 | Mar 20, 2026 | 5 |
| Krogulski Kenneth | Director | 302,338 | Mar 20, 2026 | 5 |
| Hamm John M. | VP Chief Financial Officer | 20,073 | Mar 20, 2026 | 1 |
| Bitterman Chris T. | Vice Pres Sales & Marketing | 4,683 | Mar 20, 2026 | 1 |
| Anthony Todd M. | Vice Pres Organizational Dev | 16,328 | Mar 20, 2026 | 1 |
| Jacobs Joey A | Director | 98,415 | Mar 21, 2023 | 0 |
| Pavliv Leo | SVP and Chief Development Off. | 129,618 | Jul 1, 2022 | 0 |
| Cearnal Martin E | Sr VP/Chief Commercial Officer | 163,473 | Apr 29, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 10, 2021 (view filing) | Aug 2-31 | 39 daysLate | Galante Joseph CDirector | PPurchase | +2.98K | $2.98 | +$8.88K | +8.6%37.8K after | 21 lots |
| Sep 10, 2021 (view filing) | Aug 2-31 | 39 daysLate | Jones JamesDirector | PPurchase | +882 | $2.98 | +$2.63K | +5.7%16.3K after | 21 lots |
| Sep 10, 2021 (view filing) | Aug 2-31 | 39 daysLate | Krogulski KennethDirector | PPurchase | +1.78K | $2.98 | +$5.32K | +1.0%175.6K after | 21 lots |
| Sep 10, 2021 (view filing) | Aug 2-31 | 39 daysLate | Cearnal Martin ESr VP/Chief Commercial Officer | PPurchase | +2.21K | $2.98 | +$6.57K | +1.3%169.5K after | 21 lots |
| Aug 13, 2021 (view filing) | Jul 1-30 | 43 daysLate | Krogulski KennethDirector | PPurchase | +1.78K | $3.26 | +$5.83K | +1.0%173.8K after | 21 lots |
| Aug 13, 2021 (view filing) | Jul 8-30 | 36 daysLate | Galante Joseph CDirector | PPurchase | +2.41K | $3.32 | +$8.00K | +7.4%34.8K after | 17 lots |
| Aug 13, 2021 (view filing) | Jul 8-30 | 36 daysLate | Jones JamesDirector | PPurchase | +714 | $3.32 | +$2.37K | +4.9%15.4K after | 17 lots |
| Aug 13, 2021 (view filing) | Jun 30-Jul 30 | 44 daysLate | Cearnal Martin ESr VP/Chief Commercial Officer | PPurchase | +2.31K | $3.25 | +$7.51K | +1.4%167.3K after | 22 lots |
| Jul 9, 2021 (view filing) | May 18-Jun 29 | 52 daysLate | Cearnal Martin ESr VP/Chief Commercial Officer | PPurchase | +3.15K | $3.01 | +$9.50K | +1.9%164.9K after | 30 lots |